ArticleCancer biomarkers : section A of Disease markers2017

Evaluation of PIK3CA mutations as a biomarker in Chinese breast carcinomas from Western China.

Jingliang Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.